MARIADELA MATUTE: Open Payments
NPI 1124318191 · MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$797 in 19 payments from 9 companies in 2025. Trend: 2023 $732 · 2024 $1,270 · 2025 $797
Food & beverage: $797
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 5 | $351 |
| PFIZER INC. | 4 | $95 |
| Alexion Pharmaceuticals, Inc. | 3 | $92 |
| Kite Pharma, Inc. | 1 | $79 |
| Incyte Corporation | 1 | $49 |
| Merck Sharp & Dohme LLC | 2 | $42 |
| SANOFI-AVENTIS U.S. LLC | 1 | $34 |
| Daiichi Sankyo Inc. | 1 | $30 |
| Adaptive Biotechnologies Corporation | 1 | $26 |
Products named: RYBREVANT, ULTOMIRIS, Yescarta, BESPONSA, DARZALEX, NIKTIMVO, PREVYMIS, REZUROCK.
Industry payments across FL — which companies pay providers there.
